US OptionsDetailed Quotes
VKTX241206C70000
- 0.05
- 0.000.00%
15min DelayTrading Nov 29 13:00 ET
0.00High0.00Low
0.00Open0.05Pre Close0 Volume1.17K Open Interest70.00Strike Price0.00Turnover128.32%IV32.32%PremiumDec 6, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.0198Delta0.0066Gamma1058.80Leverage Ratio-0.0320Theta0.0001Rho20.92Eff Leverage0.0027Vega
Viking Therapeutics Stock Discussion
I suspect they chose not to present the full safety profile, given that the weight loss results for the 120 mg and 280 mg QM cohorts, in obese non-diabetics (without dose escalations), at week 16 in P2 are consistent with the P1 results (see slide 1). So, it is likely that the 120 mg and 280 mg QM (without dose...
🚀🚀🚀🚀 now all engines firing
lets gooooooo
No comment yet